Our In Silico data also indicated that Apigetrin and Rutin might block human TLR4, which could be useful in type 2 diabetes protein Tetrameric 11B-HSD1I and human pancreatic alpha-amylase those our result are similar with previous literature [43]. Here, TLR4 is linked to type 2 diabetes mellitus.